Certain Sleep-Disordered Breathing Treatment Systems and Components Thereof; Commission Determination Not To Review an Initial Determination Granting an Unopposed Motion of Complainants Resmed Corp., Resmed Inc., and Resmed Ltd. To Amend the Complaint, 76858-76859 [2013-30115]

Download as PDF 76858 Federal Register / Vol. 78, No. 244 / Thursday, December 19, 2013 / Notices Act of 1930 (19 U.S.C. 1671b(a) and 1673b(a)) (the Act), that there is a reasonable indication that an industry in the United States is materially injured by reason of imports from China of 1,1,1,2-Tetrafluoroethane, provided for in subheading 2903.39.20 of the Harmonized Tariff Schedule of the United States, that are alleged to be sold in the United States at less than fair value (‘‘LTFV’’), and that are allegedly subsidized by the Government of China. emcdonald on DSK67QTVN1PROD with NOTICES Commencement of Final Phase Investigations Pursuant to section 207.18 of the Commission’s rules, the Commission also gives notice of the commencement of the final phase of its investigations. The Commission will issue a final phase notice of scheduling, which will be published in the Federal Register as provided in section 207.21 of the Commission’s rules, upon notice from the Department of Commerce (Commerce) of affirmative preliminary determinations in the investigations under sections 703(b) or 733(b) of the Act, or, if the preliminary determinations are negative, upon notice of affirmative final determinations in those investigations under sections 705(a) or 735(a) of the Act. Parties that filed entries of appearance in the preliminary phase of the investigations need not enter a separate appearance for the final phase of the investigations. Industrial users, and, if the merchandise under investigation is sold at the retail level, representative consumer organizations have the right to appear as parties in Commission antidumping and countervailing duty investigations. The Secretary will prepare a public service list containing the names and addresses of all persons, or their representatives, who are parties to the investigations. Background On October 22, 2013, a petition was filed with the Commission and Commerce by Mexichem Fluor Inc., St. Gabriel, LA, alleging that an industry in the United States is materially injured or threatened with material injury by reason of LTFV and subsidized imports of 1,1,1,2-Tetrafluoroethane from China. Accordingly, effective October 22, 2013, the Commission instituted countervailing duty investigation No. 701–TA–509 and antidumping duty investigation No. 731–TA–1244 (Preliminary). Notice of the institution of the Commission’s investigations and of a public conference to be held in connection therewith was given by posting copies of the notice in the Office VerDate Mar<15>2010 16:41 Dec 18, 2013 Jkt 232001 of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register of October 28, 2013 (78 FR 64243). The conference was held in Washington, DC, on November 12, 2013, and all persons who requested the opportunity were permitted to appear in person or by counsel. The Commission transmitted its determinations in these investigations to the Secretary of Commerce on December 13, 2013. The views of the Commission are contained in USITC Publication 4444 (December 2013), entitled 1,1,1,2Tetrafluoroethane from China, Investigation Nos. 701–TA–509 and 731–TA–1244 (Preliminary). Dated: December 13, 2013. By order of the Commission. Lisa R. Barton, Acting Secretary to the Commission. [FR Doc. 2013–30159 Filed 12–18–13; 8:45 am] BILLING CODE 7020–02–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–890] Certain Sleep-Disordered Breathing Treatment Systems and Components Thereof; Commission Determination Not To Review an Initial Determination Granting an Unopposed Motion of Complainants Resmed Corp., Resmed Inc., and Resmed Ltd. To Amend the Complaint U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission has determined not to review an initial determination (‘‘ID’’) (Order No. 4) of the presiding administrative law judge granting an unopposed motion of complainants Resmed Corp., Resmed Inc., and Resmed Ltd. to amend the complaint in the above-captioned investigation. FOR FURTHER INFORMATION CONTACT: James A. Worth, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–3065. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW., Washington, DC 20436, telephone (202) 205–2000. General information concerning the Commission SUMMARY: PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 may also be obtained by accessing its Internet server (http://www.usitc.gov). The public record for this investigation may be viewed on the Commission’s electronic docket (EDIS) at http:// edis.usitc.gov. Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal on (202) 205–1810. SUPPLEMENTARY INFORMATION: The Commission instituted this investigation on Friday, August 23, 2013, based on a complaint filed on July 19, 2013, on behalf of ResMed Corp. of San Diego, California; ResMed Inc. of San Diego, California; and ResMed Ltd. of Bella Vista, Australia (collectively, ‘‘Complainants’’). 78 FR 52563 (August 23, 2013). The complaint alleged violations of Section 337 of the Tariff Act of 1930, as amended, 19 U.S.C. 1337, in the sale for importation, importation, or sale within the United States after importation of certain sleepdisordered breathing treatment systems and components thereof by reason of infringement of one or more of claims 32–37, 53, 79, 80, and 88 of U.S. Patent No. 7,997,267; claims 1–7 of U.S. Patent No. 7,614,398; claim 1 of U.S. Patent No. 7,938,116; claims 30, 37, and 38 of U.S. Patent No. 7,341,060; claims 1, 3, 5, 11, 28, 30, 31, and 56 of U.S. Patent No. 8,312,883; claims 13, 15, 16, 26–28, 51, 52, and 55 of U.S. Patent No. 7,926,487; claims 1, 3, 6, 7, 9, 29, 32, 35, 40, 42, 45, 50, 51, 56, 59, 89, 92, 94, and 96 of U.S. Patent No. 7,178,527; and claims 19–24, 26, 29–36, and 39–41 of U.S. Patent No. 7,950,392. The Commission’s notice of investigation named as respondents BMC Medical Co., Ltd. of Beijing, China; 3B Medical, Inc. of Lake Wales, Florida; and 3B Products, L.L.C. of Lake Wales, Florida (collective, ‘‘the Respondents’’). A Commission investigative attorney (‘‘IA’’) is also participating in this investigation. On October 30, 2013, Complainants filed an unopposed motion to amend the Complaint to correct an error in its allegations regarding the domestic industry. The motion stated that neither the Respondents nor the IA opposed the motion to amend. On November 21, 2013, the ALJ issued an ID, finding good cause shown and granting Complainants’ motion. There were no petitions for review. Having considered the ID, the Commission has determined not to review the subject ID. This action is taken under the authority of section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and § 210.42 of the Commission’s Rules E:\FR\FM\19DEN1.SGM 19DEN1 Federal Register / Vol. 78, No. 244 / Thursday, December 19, 2013 / Notices —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. of Practice and Procedure (19 CFR 210.42). By order of the Commission. Issued: December 13, 2013. Lisa R. Barton, Acting Secretary to the Commission. [FR Doc. 2013–30115 Filed 12–18–13; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Bureau of Alcohol, Tobacco, Firearms and Explosives [OMB Number 1140–0017] Agency Information Collection Activities; Proposed Collection; Comments Requested: Annual Firearms Manufacturing and Exportation Report Under United States Code, Firearms emcdonald on DSK67QTVN1PROD with NOTICES ACTION: 60-Day notice. The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted for ‘‘sixty days’’ until February 18, 2014. This process is conducted in accordance with 5 CFR 1320.10. If you have comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Thomas DiDomenico, Firearms and Explosives Services Division at AFMERQuestions@atf.gov. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; VerDate Mar<15>2010 16:41 Dec 18, 2013 Jkt 232001 76859 DEPARTMENT OF JUSTICE Summary of Information Collection The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies. Comments are encouraged and will be accepted for ‘‘sixty days’’ until February 18, 2014. This process is conducted in accordance with 5 CFR 1320.10. If you have comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Joseph Fox, Branch Chief, Alcohol and Tobacco Enforcement Branch, Bureau of Alcohol, Tobacco, Firearms and Explosives at Joseph.Fox@ atf.gov. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Annual Firearms Manufacturing and Exportation Report under 18 U.S.C. Chapter 44, Firearms. (3) Agency form number, if any, and the applicable component of the Department of Justice sponsoring the collection: Form Number: ATF F 5300.11. Bureau of Alcohol, Tobacco, Firearms and Explosives. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Business or other forprofit. Other: Federal Government, State, Local, or Tribal Government. Need for Collection ATF collects this data for the purpose of witness qualifications, congressional investigations, court decision and disclosure and furnishing information to other Federal agencies. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: It is estimated that 8,500 respondents will complete a 20 minute form. (6) An estimate of the total public burden (in hours) associated with the collection: There are an estimated 2,833 annual total burden hours associated with this collection. If additional information is required contact: Jerri Murray, Department Clearance Officer, Policy and Planning Staff, Justice Management Division, Department of Justice, Two Constitution Square, 145 N Street NE., Room 3W– 1407B, Washington, DC 20530. Dated: December 13, 2013. Jerri Murray, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2013–30153 Filed 12–18–13; 8:45 am] BILLING CODE 4410–FY–P PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Bureau of Alcohol, Tobacco, Firearms and Explosives [OMB Number 1140–0098] Agency Information Collection Activities: Proposed Collection; Comments Requested: Prevent All Cigarette Trafficking (PACT) Act Registration Form ACTION: E:\FR\FM\19DEN1.SGM 60-Day notice. 19DEN1

Agencies

[Federal Register Volume 78, Number 244 (Thursday, December 19, 2013)]
[Notices]
[Pages 76858-76859]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-30115]


-----------------------------------------------------------------------

 INTERNATIONAL TRADE COMMISSION

[Investigation No. 337-TA-890]


Certain Sleep-Disordered Breathing Treatment Systems and 
Components Thereof; Commission Determination Not To Review an Initial 
Determination Granting an Unopposed Motion of Complainants Resmed 
Corp., Resmed Inc., and Resmed Ltd. To Amend the Complaint

AGENCY: U.S. International Trade Commission.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the U.S. International Trade 
Commission has determined not to review an initial determination 
(``ID'') (Order No. 4) of the presiding administrative law judge 
granting an unopposed motion of complainants Resmed Corp., Resmed Inc., 
and Resmed Ltd. to amend the complaint in the above-captioned 
investigation.

FOR FURTHER INFORMATION CONTACT: James A. Worth, Office of the General 
Counsel, U.S. International Trade Commission, 500 E Street SW., 
Washington, DC 20436, telephone (202) 205-3065. Copies of non-
confidential documents filed in connection with this investigation are 
or will be available for inspection during official business hours 
(8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. 
International Trade Commission, 500 E Street SW., Washington, DC 20436, 
telephone (202) 205-2000. General information concerning the Commission 
may also be obtained by accessing its Internet server (http://www.usitc.gov). The public record for this investigation may be viewed 
on the Commission's electronic docket (EDIS) at http://edis.usitc.gov. 
Hearing-impaired persons are advised that information on this matter 
can be obtained by contacting the Commission's TDD terminal on (202) 
205-1810.

SUPPLEMENTARY INFORMATION: The Commission instituted this investigation 
on Friday, August 23, 2013, based on a complaint filed on July 19, 
2013, on behalf of ResMed Corp. of San Diego, California; ResMed Inc. 
of San Diego, California; and ResMed Ltd. of Bella Vista, Australia 
(collectively, ``Complainants''). 78 FR 52563 (August 23, 2013). The 
complaint alleged violations of Section 337 of the Tariff Act of 1930, 
as amended, 19 U.S.C. 1337, in the sale for importation, importation, 
or sale within the United States after importation of certain sleep-
disordered breathing treatment systems and components thereof by reason 
of infringement of one or more of claims 32-37, 53, 79, 80, and 88 of 
U.S. Patent No. 7,997,267; claims 1-7 of U.S. Patent No. 7,614,398; 
claim 1 of U.S. Patent No. 7,938,116; claims 30, 37, and 38 of U.S. 
Patent No. 7,341,060; claims 1, 3, 5, 11, 28, 30, 31, and 56 of U.S. 
Patent No. 8,312,883; claims 13, 15, 16, 26-28, 51, 52, and 55 of U.S. 
Patent No. 7,926,487; claims 1, 3, 6, 7, 9, 29, 32, 35, 40, 42, 45, 50, 
51, 56, 59, 89, 92, 94, and 96 of U.S. Patent No. 7,178,527; and claims 
19-24, 26, 29-36, and 39-41 of U.S. Patent No. 7,950,392. The 
Commission's notice of investigation named as respondents BMC Medical 
Co., Ltd. of Beijing, China; 3B Medical, Inc. of Lake Wales, Florida; 
and 3B Products, L.L.C. of Lake Wales, Florida (collective, ``the 
Respondents''). A Commission investigative attorney (``IA'') is also 
participating in this investigation.
    On October 30, 2013, Complainants filed an unopposed motion to 
amend the Complaint to correct an error in its allegations regarding 
the domestic industry. The motion stated that neither the Respondents 
nor the IA opposed the motion to amend. On November 21, 2013, the ALJ 
issued an ID, finding good cause shown and granting Complainants' 
motion. There were no petitions for review.
    Having considered the ID, the Commission has determined not to 
review the subject ID.
    This action is taken under the authority of section 337 of the 
Tariff Act of 1930, as amended (19 U.S.C. 1337), and Sec.  210.42 of 
the Commission's Rules

[[Page 76859]]

of Practice and Procedure (19 CFR 210.42).

    By order of the Commission.

    Issued: December 13, 2013.
Lisa R. Barton,
Acting Secretary to the Commission.
[FR Doc. 2013-30115 Filed 12-18-13; 8:45 am]
BILLING CODE 7020-02-P